Cargando…

Effects of selective serotonin reuptake inhibitors on glaucoma: A nationwide population-based study

BACKGROUND: Selective serotonin reuptake inhibitors (SSRIs) are one of the most commonly prescribed classes of antidepressants. Glaucoma is the second leading cause of blindness globally and iatrogenic glaucoma has been implicated across disparate medication classes. Available studies that have soug...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Vincent Chin-Hung, Ng, Mei-Hing, Chiu, Wei-Che, McIntyre, Roger S., Lee, Yena, Lin, Tsang-Yaw, Weng, Jun-Cheng, Chen, Pau-Chung, Hsu, Chung-Yao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5336262/ https://www.ncbi.nlm.nih.gov/pubmed/28257449 http://dx.doi.org/10.1371/journal.pone.0173005

Ejemplares similares

The Association between Selective Serotonin Reuptake Inhibitors (SSRIs) Use and the Risk of Bladder Cancer: A Nationwide Population-Based Cohort Study
por: Liu, Yi-Chun, et al.
Publicado: (2020)

Association between selective serotonin reuptake inhibitor and risk of peripheral artery disease in diabetes mellitus: Propensity score matching and landmark analysis
por: Chen, Kai-Hua, et al.
Publicado: (2022)

Long-Term Use of Selective Serotonin Reuptake Inhibitors and Risk of Glaucoma in Depression Patients
por: Chen, Hsin-Yi, et al.
Publicado: (2015)

Association of Tic Disorders and Enterovirus Infection: A Nationwide Population-Based Study
por: Tsai, Ching-Shu, et al.
Publicado: (2016)

Antidepressants and Gastric Cancer: A Nationwide Population-Based Nested Case-Control Study
por: Hsieh, Yi-Hsuan, et al.
Publicado: (2015)

Antidepressant medication use and nasopharyngeal cancer risk: a nationwide population-based study
por: Lin, Chiao-Fan, et al.
Publicado: (2018)

Endometrial cancer and antidepressants: A nationwide population-based study
por: Lin, Chiao-Fan, et al.
Publicado: (2016)

Hepatocellular carcinoma and antidepressants: a nationwide population-based study
por: Chen, Vincent Chin-Hung, et al.
Publicado: (2016)

Invasive Cervical Cancer and Antidepressants: A Nationwide Population-Based Study
por: Chan, Hsiang-Lin, et al.
Publicado: (2015)

Asthma, corticosteroid use and schizophrenia: A nationwide population-based study in Taiwan
por: Wang, Wei-Chen, et al.
Publicado: (2017)

Sentiment Analysis of Online Reviews for Selective Serotonin Reuptake Inhibitors and Serotonin–Norepinephrine Reuptake Inhibitors
por: Compagner, Chad, et al.
Publicado: (2021)

Antipsychotic use is inversely associated with gastric cancer risk: A nationwide population‐based nested case‐control study
por: Hsieh, Yi‐Hsuan, et al.
Publicado: (2019)

Exposure to selective serotonin reuptake inhibitors and the risk of congenital malformations: a nationwide cohort study
por: Jimenez-Solem, Espen, et al.
Publicado: (2012)

Clinical pharmacology of serotonin selective reuptake inhibitors /
por: Preskorn, Sheldon
Publicado: (1996)

Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia
por: Welsch, Patrick, et al.
Publicado: (2018)

Selective serotonin reuptake inhibitors and Alzheimer’s disease
por: Mdawar, Bernadette, et al.
Publicado: (2019)

Selective serotonin reuptake inhibitor use in hip fracture patients: a Danish nationwide prevalence study
por: Bruun, Stine B, et al.
Publicado: (2019)

Serotonin syndrome triggered by postoperative administration of serotonin noradrenaline reuptake inhibitor (SNRI)
por: Takata, Junko, et al.
Publicado: (2019)

The association between methylphenidate treatment and the risk for fracture among young ADHD patients: A nationwide population-based study in Taiwan
por: Chen, Vincent Chin-Hung, et al.
Publicado: (2017)

Correction: The association between methylphenidate treatment and the risk for fracture among young ADHD patients: A nationwide population-based study in Taiwan
por: Chen, Vincent Chin-Hung, et al.
Publicado: (2017)

Effect of Serotonin Reuptake Inhibitors on Pulmonary Hemodynamics in Humans
por: Pleym, Hilde, et al.
Publicado: (2011)

Serotonin reuptake inhibitor antidepressants (SSRIs) against atherosclerosis
por: Wozniak, Greta, et al.
Publicado: (2011)

Heart Rate Recovery and Selective Serotonin Reuptake Inhibitors
por: Cerit, Levent
Publicado: (2016)

Selective serotonin reuptake inhibitor-induced galactorrhea with hyperprolactinemia
por: Bhattacharjee, Subir, et al.
Publicado: (2021)

Confounding by Indication in Studies of Selective Serotonin Reuptake Inhibitors
por: Lee, Jimin, et al.
Publicado: (2022)

Use of Selective Serotonin Reuptake Inhibitors and Risks of Stroke in Patients with Obsessive Compulsive Disorder: A Population-Based Study
por: Chu, Che-Sheng, et al.
Publicado: (2016)

Selective serotonin reuptake inhibitors and the risk of hepatocellular carcinoma in hepatitis B virus-infected patients
por: Chang, Chia-Ming, et al.
Publicado: (2017)

Premenopausal Singaporean Women Suffering from Major Depressive Disorder Treated with Selective Serotonin Reuptake Inhibitors Had Similar Bone Mineral Density as Compared with Healthy Controls
por: Ho, Roger C., et al.
Publicado: (2022)

Use of serotonin reuptake inhibitors and risk of subsequent bone loss in a nationwide population-based cohort study
por: Kang, Sunyoung, et al.
Publicado: (2021)

COVID-19 mortality among selective serotonin reuptake inhibitor users—results from a nationwide cohort
por: Stauning, Marius Ahm, et al.
Publicado: (2023)

Selective serotonin reuptake inhibition modulates response inhibition in Parkinson’s disease
por: Ye, Zheng, et al.
Publicado: (2014)

Transient Serotonin Syndrome Caused by Concurrent Use of Tramadol and Selective Serotonin Reuptake Inhibitor
por: Shakoor, Muhammad Tariq, et al.
Publicado: (2014)

Selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for anxiety, obsessive-compulsive, and stress disorders: A 3-level network meta-analysis
por: Gosmann, Natan Pereira, et al.
Publicado: (2021)

The Efficacy and Safety of Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors in the Treatment of Menopausal Hot Flashes: A Systematic Review of Clinical Trials
por: Azizi, Marzieh, et al.
Publicado: (2022)

Clinical Utility of Semistructured Interview and Scales to Assess Withdrawal Syndromes With Dose Reduction or Discontinuation of Selective Serotonin Reuptake Inhibitors or Serotonin Norepinephrine Reuptake Inhibitors
por: Cosci, Fiammetta, et al.
Publicado: (2022)

Overcoming Resistance to Selective Serotonin Reuptake Inhibitors: Targeting Serotonin, Serotonin-1A Receptors and Adult Neuroplasticity
por: Vahid-Ansari, Faranak, et al.
Publicado: (2019)

Candidate genes for antidepressant response to selective serotonin reuptake inhibitors
por: Lotrich, Francis E, et al.
Publicado: (2005)

Improvement of social adaptation in depression with serotonin and norepinephrine reuptake inhibitors
por: Briley, Mike, et al.
Publicado: (2010)

Prenatal exposure to serotonin reuptake inhibitors: a case report
por: Marsella, Maria, et al.
Publicado: (2010)

Serotonin-Norepinephrine Reuptake Inhibitors for Pain Control: Premise and Promise
por: Marks, David M, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_mki5ttfjmsbgi024hodihqa44u